9.00MMarket Cap
LossP/E TTM
AKTX Balance Sheet
You can check out the annual or quarterly balance sheets of Akari Therapeutics PLC here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing AKTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Akari Therapeutics PLC Have?
In its most recent quarterly, Akari Therapeutics PLC had 2.77M in cash and cash equivalents.
How Much Are Akari Therapeutics PLC's Total Liabilities?
Akari Therapeutics PLC reported 19.56M in total liabilities as of the latest reported quarter, including 12.35M in current liabilities and 7.21M in non-current liabilities.
What Are Akari Therapeutics PLC's Total Assets?
As of the latest reported quarter, Akari Therapeutics PLC's total assets were 47.89M, consisting of 5.46M in current assets and 42.43M in non-current assets.
How Much Shareholders' Equity Does Akari Therapeutics PLC Have?
Akari Therapeutics PLC reported 28.33M in total shareholders' equity as of the latest reported quarter.